Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy. - Wikidata - wikimedia - TriplyDB

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

http://www.wikidata.org/entity/Q34781865

about

Stepwise approach to myopathy in systemic disease Toxic myopathies The Immune System of HIV-Exposed Uninfected Infants Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine.Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats Neurological and psychiatric adverse effects of antiretroviral drugs.Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.Antiretroviral therapy in macrophages: implication for HIV eradication.Zidovudine exposure in HIV-1 infected Tanzanian women increases mitochondrial DNA levels in placenta and umbilical cords Neuropsychiatric Effects of HIV Antiviral Medications.Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis Antiretroviral therapy-associated acute motor and sensory axonal neuropathy Mitochondrial toxicity studied with the PBMC of children from the Chinese national pediatric highly active antiretroviral therapy cohort.Toxicity and tolerance mechanisms for azidothymidine, a replication gap-promoting agent, in Escherichia coli.A modern approach to the treatment of mitochondrial disease Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysis.Evidence of Subclinical mtDNA Alterations in HIV-Infected Pregnant Women Receiving Combination Antiretroviral Therapy Compared to HIV-Negative Pregnant Women.Antiretroviral therapy in Indian setting: when & what to start with, when & what to switch to?Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.Virological Response and Muscular Adverse Events during Long-Term Clevudine Therapy in Chronic Hepatitis B Patients.Health-related quality of life and physical functioning in people living with HIV/AIDS: a case-control design.Modulation of mitochondrial bioenergetics in a skeletal muscle cell line model of mitochondrial toxicity.Drugs interfering with mitochondrial disorders.A review of the toxicity of HIV medications.Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity.Quantification of mitochondrial toxicity in HIV-infected individuals by quantitative PCR compared to flow cytometry.Drug transporter pharmacogenetics in nucleoside-based therapies.Neuromuscular complications in HIV: effects of aging.New paradigms in hepatitis B management: only diamonds are forever.The stress response resolution assay. I. Quantitative assessment of environmental agent/condition effects on cellular stress resolution outcomes in epithelium.Geriatric syndromes: new frontiers in HIV and sarcopenia.Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.Clevudine Induced Mitochondrial Myopathy.Hydroxycloroquine-induced oxidative stress on sciatic nerve and muscle tissue of rats: a stereological and biochemical study.Nano-NRTIs: efficient inhibitors of HIV type-1 in macrophages with a reduced mitochondrial toxicity.Effect of Zidovudine and its interaction with rocuronium on neuromuscular transmission.Zidovudine-induced myopathy: A study in Indian patients.Author's reply.

P2860

Q21090471-FA4393E9-5B73-4819-BE29-464E621EF67B Q27007256-1E26BCDA-C5E0-4CBE-931E-8706C73E1FD3 Q28069872-20EACADB-05DB-4329-B6D6-0DFE20C5BD21 Q28486041-01324476-A299-4865-A783-5298AFA0D13E Q28550222-E4BB2B12-64D7-4B92-B5F1-CEF3FE4D5159 Q34039419-AAC12DB4-CCA2-4453-9C4F-D65A148CE143 Q34152110-F1C638E9-2C41-45FB-99C0-D62B2E52F6DF Q34298792-1813A4C5-F78F-4C8E-B76C-E63799DE8A49 Q34358732-7ABBC687-6568-41C1-B636-D3FADBCE77B9 Q34537705-B8FA1150-0043-4124-B453-51470799B03E Q34561763-39A206B4-BB14-4041-B574-056C6D80862C Q34569959-64A4B9F5-7571-45EC-A576-1C831F89E333 Q34611901-9C5ECB06-589D-4C30-AE50-01B6A0EA852D Q34612485-BEBA9F26-D503-4A7B-A6A9-F15C7F32312C Q35011397-2E64A903-6E84-4A1A-9F61-3EC3A6CA3031 Q35022510-67A8D68F-7422-4869-BEEB-771AD90583BF Q35579416-C7E7EDBF-306E-452F-B0E1-0D16C3093B53 Q35620025-DCE5D17B-F07E-41B5-83EB-3F802F4E145A Q35738557-CD5784F4-5EE3-4464-8761-2C8C22E604DA Q35770848-B756B32D-08DF-42F8-85E6-82D75D1E8624 Q36115648-974A7507-DAA0-49CD-954D-D03CE6CC1AAE Q36957080-30F10998-E080-4FBC-892D-F8382AE7F95C Q36972700-4AC02E90-2131-4959-B2B7-EE26B7C62513 Q37541019-DB539A64-6EEB-4816-A878-75F6B57D8C18 Q37617357-18D156F0-22D3-41CC-B09B-B7707677BBA1 Q37633495-B402D34B-D94B-40DA-B75B-D3F8ACD7FC2E Q37634512-A5C8B3B0-D520-4D0C-886F-5703AA3D2F9A Q37663941-830EE47D-082C-496B-9FE2-AF6CE038B9DB Q37760954-04321A7C-CEAF-430F-93C7-C25E500104EF Q37972273-8F039A1D-9F68-43D2-9F27-E917541AC0C9 Q38588187-E2E9617D-4F36-4FD2-B7C1-AB9A3CD0AFBE Q39171826-4AA2E741-DF2E-4AAD-B598-D7530D706E74 Q39283725-8FB52D2C-EF4F-4236-B067-E0A65A772FB1 Q40640593-BB078641-1959-4840-88A0-06D2411DAA64 Q41928276-F371CEF1-FDBD-4D57-9B83-6BC3EC83699A Q41929070-032DEB1C-B790-41FA-BEE8-43695C6FB31C Q41972161-7D869248-71F8-4009-9790-D0359CAC4D24 Q42577628-99C367B8-2992-4CB9-B023-0035A098A60D Q42728492-014FAF4D-5A7C-46F0-9704-E2A4AC1D8832 Q42872435-A86A0575-3234-4E82-A06A-A6A625609708

P2860

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

http://www.wikidata.org/entity/Q34781865

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@ast

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@en

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@nl

type

label

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@ast

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@en

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@nl

prefLabel

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@ast

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@en

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@nl

P1433

Q34781865-95D24640-476B-43DE-AB7D-B5680C81B010

P1476

Q34781865-B0E87581-9B48-4A5E-93E7-EB3AADA1EB80

P2093

Q34781865-51AAA46B-D87B-49C5-8C80-FE1795F03FD4

Q34781865-9C59A044-8937-4591-8232-6B4C8FEC121E

P2860

Q34781865-0C94EFAA-D323-4CAF-B459-A6EABA0EBF1F

Q34781865-0CA98746-E36A-4B49-A2A7-4805513D9CDF

Q34781865-0DFE184E-84B7-4730-A757-395CEC5D9ED6

Q34781865-370B103A-9441-490B-9225-F9AB2C59A1CB

Q34781865-462198FF-0B49-477B-9F58-CE3790343EC0

Q34781865-B00E2B53-5826-45CE-ABE4-1C21D0EB6D4A

Q34781865-B76F88C3-AB70-484A-B0A0-22F8D69DAA28

Q34781865-E475C618-B8F3-4468-9549-CDB234B0B391

Q34781865-E52E4316-62A7-4AB6-909B-F5C6186FF00C

Q34781865-E8258743-A0C1-46A6-B643-31F967647236

P304

Q34781865-68D05449-2230-4C39-8839-B4E5DA40EB2B

P31

Q34781865-1DD6F2ED-D1AD-483D-926B-0E5C00F433B5

P356

Q34781865-CD8FFBB7-E882-4F97-9BB9-CB9AB7C12811

P433

Q34781865-2C77C21E-2465-412F-8C1B-1CC44C57AF1D

P478

Q34781865-3C92E0E3-DA65-4CD3-A98A-26501D818FC2

P577

Q34781865-4E2F7A24-F3C7-409D-BFE3-32A02B28E042

P698

Q34781865-0E2E9849-69DE-464B-86CD-92BC32843D6C

P356

P1433

P1476

Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.

@en

P2093

Amie J Dirks Naylor

http://www.w3.org/2001/XMLSchema#string

Erin R Scruggs

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondrial myopathy caused by long-term zidovudine therapy

Mitochondrial dna depletion, oxidative stress, and mutation: mechanisms of dysfunction from nucleoside reverse transcriptase inhibitors.

Lipoapoptosis: its mechanism and its diseases.

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.

Effects of AZT and RNA-protein complex (FA-2-b-beta) extracted from Liang Jin mushroom on apoptosis of gastric cancer cells.

The universality of bioenergetic disease and amelioration with redox therapy.

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.

Beneficial effects of L-carnitine in myoblastic C2C12 cells. Interaction with zidovudine.

Potential role for Id myogenic repressors in apoptosis and attenuation of hypertrophy in muscles of aged rats.

Denervation stimulates apoptosis but not Id2 expression in hindlimb muscles of aged rats.

P304

83-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000134943

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18504416

http://www.w3.org/2001/XMLSchema#string